Clinical Trial Update: Ziv-aflibercept Efficacy in Better Regulating AMD [Phase 2]

View source ↗

Summary

Phase 2 trial update on ziv-aflibercept for wet macular degeneration shows efficacy signals in regulating disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration
• Wet Macular Degeneration

Drugs mentioned

• Ziv-aflibercept (ziv-aflibercept)

Snippet

Sponsor: Kapil Kapoor | Conditions: Wet Macular Degeneration, Wet Age-related Macular Degeneration | Phase 2 | Status: COMPLETED